Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020
FREEHOLD, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it will present at the 32nd Annual ROTH Conference being held on March 15-17, 2020 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.
- FREEHOLD, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it will present at the 32nd Annual ROTH Conference being held on March 15-17, 2020 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.
- David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare is scheduled to present on Monday, March 16, at 3:30 p.m. Pacific Time.
- The 32nd Annual ROTH Conference is scheduled for March 15-17, 2020 at The Ritz Carlton, Laguna Niguel in Orange County, CA.
- Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics.